CorMedix Inc. (CRMD) Form 10-K Annual Reports
CorMedix Inc. (CRMD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CRMD
CIK: 1410098
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Cohen
Audit LocationMorristown, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-18 | 2026-09-18 | 4 Filing | 0001213900-26-101594 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-29 | 4 Filing | 0001213900-26-096386 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-29 | 4 Filing | 0001213900-26-096385 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-29 | 4 Filing | 0001213900-26-096383 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001410098-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001410098-26-000054 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001410098-26-000044 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-29 | 8-K | 0001410098-26-000040 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-25 | 8-K | 0001410098-26-000037 | View SEC Doc Filr Page |
| S-8 POS | 2026-06-25 | — | S-8 POS | 0001410098-26-000032 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-23 | 8-K | 0001410098-26-000028 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-12 | — | SCHEDULE 13G/A Filing | 0002063837-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-06-12 | — | SCHEDULE 13G/A Filing | 0002063837-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-08 | CURRENT REPORT | 0001213900-26-066061 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002026 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001410098-26-000021 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001410098-26-000020 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001213900-26-049323 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-29 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-049317 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-23 | PROXY STATEMENT | 0001213900-26-049311 | View SEC Doc Filr Page |
| 8-K | 2026-04-27 | 2026-04-27 | CURRENT REPORT | 0001213900-26-047748 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-17 | 2026-04-17 | PROXY STATEMENT | 0001213900-26-045165 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-001102 | View SEC Doc Filr Page |
| 8-K | 2026-03-06 | 2026-03-06 | CURRENT REPORT | 0001213900-26-024777 | View SEC Doc Filr Page |
| 10-K | 2026-03-05 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-023889 | View SEC Doc Filr Page |